You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -340.6% | -92.9% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -1.8 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 14.7 | 6.0 |
Price / Book value | 25.7 |
Latest | Forecast | |
---|---|---|
Revenue | -37.7% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-05-31 | 0.51 | -9.78 | -13.36p | -8.3 | 0.0 | n/a | n/a | 0.0% |
2021-05-31 | 3.72 | -6.06 | -7.73p | -27.0 | 0.0 | n/a | n/a | 0.0% |
2022-08-31 | 2.32 | -6.58 | -7.91p | -11.2 | 0.0 | n/a | n/a | 0.0% |
2023-08-31 | 1.15 | -5.93 | -8.47p | -2.7 | 0.0 | n/a | n/a | 0.0% |
Oncimmune secures three new contracts Sharecast News | 31 Oct |
---|---|
Oncimmune Holdings announces major recapitalisation Sharecast News | 18 Oct |
Oncimmune shares surge on contract wins Sharecast News | 09 Sep |
Holding(s) in Company | 13-Nov-24 17:06 |
---|---|
Holding(s) in Company | 13-Nov-24 11:42 |
Holding(s) in Company | 12-Nov-24 17:18 |
Holding(s) in Company | 12-Nov-24 16:49 |
Director/PDMR Shareholding | 11-Nov-24 11:16 |